NCT04348227Unknown不适用
How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?
Hôpital Universitaire Fattouma Bourguiba1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2019年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- MDR pathogens in endotracheal aspirates
研究概览
简要总结
A previous study showed a high incidence of ventilator-associated pneumonia to multidrug resistant pathogens in our ICU. That has been related to lack of compliance to hand hygiene among health care providers in ou ICU.
详细描述
A single-center cohort study performed in the department of Anesthesia and Intensive Care in our Hospital. All endotracheal isolates realised in the period of study are collected from the Department of Microbiology of our Hospital.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients requiring mechanical ventilation for more than 24 hours
排除标准
- 未提供
结局指标
主要结局
MDR pathogens in endotracheal aspirates
时间窗: 1 year
Incidence of MDR bacteria in endotracheal aspirates
次要结局
- Microorganisms in endotracheal aspirates(1 year)
研究者
Khemili Malek
Principal investigator
Hôpital Universitaire Fattouma Bourguiba
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 PatientsInfectionsCritical IllnessOrgan Failure, MultipleVentilator Associated PneumoniaSeptic ShockSuperinfectionNCT05972980University of Turin, Italy200
Unknown
不适用
The Impact of Covid-19 Hospital Care on the Prevalence of MDRO in IndonesiaAntibiotic Resistant InfectionCOVID-19NCT05293483Erasmus Medical Center1,110
已完成
不适用
Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers.Enterobacteriaceae InfectionsNCT04276480University Hospital, Bordeaux9
Unknown
不适用
Effects of COVID-19 Infection and Critical Illness on Diaphragm Tissue Characteristics and Movement, Visualized With MRIDiaphragm DiseaseCovid19NCT04735757Amsterdam UMC, location VUmc40
已完成
4 期
Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy TrialCOVID-19NCT05822583University of Minnesota285